CYFIP2 and cancer: The increased expression of WDR4, METTTL1, NUDT1, and CYFIP2 enhanced the sensitivity of some anti-cancer drugs such as hydroxyurea, L-asparaginase, 5-fluoro-deoxy-uridine 10mer, and chelerythrine.